Edition:
United Kingdom

Fluidigm Corp (FLDM.OQ)

FLDM.OQ on NASDAQ Stock Exchange Global Select Market

7.76USD
16 Feb 2018
Change (% chg)

$-0.21 (-2.63%)
Prev Close
$7.97
Open
$7.95
Day's High
$8.38
Day's Low
$7.69
Volume
80,135
Avg. Vol
75,207
52-wk High
$8.38
52-wk Low
$2.52

Chart for

About

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company's core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing... (more)

Overall

Beta: 3.36
Market Cap(Mil.): $181.36
Shares Outstanding(Mil.): 38.51
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 148.59 16.64
EPS (TTM): -- -- --
ROI: -- 9.38 10.66
ROE: -- 14.72 14.30

BRIEF-Fluidigm Announces Qtrly Loss Per Share $0.27

* FLUIDIGM ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND OPERATIONAL PROGRESS

08 Feb 2018

BRIEF-Fluidigm posts Q3 adj. loss per share $0.25​

* Fluidigm announces third quarter financial results and operational progress

02 Nov 2017

BRIEF-Fluidigm enters into distribution agreement with University Of Zurich

* Fluidigm Corp - ‍ Entered into a distribution agreement with University Of Zurich to offer histocat software for multiparameter tissue analysis​ Source text for Eikon: Further company coverage:

24 Oct 2017

BRIEF-Neuberger Berman Group LLC reports 13.65 percent passive stake in Fluidigm

* Neuberger Berman Group LLC reports a 13.65 percent passive stake in Fluidigm Corp as of August 31, 2017 - sec filing‍​ Source text : [ID:http://bit.ly/2eL1ifW] Further company coverage:

08 Sep 2017

Earnings vs. Estimates